AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 68 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,779,508 | -57.0% | 1,744,616 | -22.9% | 0.00% | -57.1% |
| Q1 2024 | $4,140,697 | +1198.5% | 2,262,676 | +779.8% | 0.01% | +600.0% |
| Q4 2023 | $318,895 | +130.4% | 257,173 | +111.8% | 0.00% | – |
| Q3 2023 | $138,414 | -65.3% | 121,416 | -72.2% | 0.00% | -100.0% |
| Q2 2023 | $399,186 | +4557.4% | 436,269 | +2836.8% | 0.00% | – |
| Q4 2022 | $8,571 | -87.0% | 14,855 | -92.9% | 0.00% | – |
| Q3 2022 | $66,000 | -68.7% | 209,755 | -64.9% | 0.00% | -100.0% |
| Q2 2022 | $211,000 | +33.5% | 598,379 | +1339.7% | 0.00% | 0.0% |
| Q2 2021 | $158,000 | -46.3% | 41,564 | +92.3% | 0.00% | -50.0% |
| Q2 2020 | $294,000 | – | 21,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |